慢性肾脏病中的磷结合剂：坏消息还是好消息？ - Suppr

Suppr

超能文献

Phosphate binders in CKD: bad news or good news?

作者信息

Drüeke Tilman B, Massy Ziad A

出版信息

J Am Soc Nephrol. 2012 Aug;23(8):1277-80. doi: 10.1681/ASN.2012060569. Epub 2012 Jul 12.

DOI:10.1681/ASN.2012060569

PMID:22797178

Abstract

摘要

相似文献

Phosphate binders in CKD: bad news or good news?慢性肾脏病中的磷结合剂：坏消息还是好消息？

J Am Soc Nephrol. 2012 Aug;23(8):1277-80. doi: 10.1681/ASN.2012060569. Epub 2012 Jul 12.

Chronic kidney disease: Phosphate binder therapy--cracks in the tower of strength?慢性肾脏病：磷结合剂治疗——坚固堡垒出现裂痕？

Nat Rev Nephrol. 2012 Nov;8(11):615-6. doi: 10.1038/nrneph.2012.219. Epub 2012 Oct 9.

Effects of phosphate binders in moderate CKD.中重度 CKD 患者的磷酸盐结合剂治疗效果。

J Am Soc Nephrol. 2012 Aug;23(8):1407-15. doi: 10.1681/ASN.2012030223. Epub 2012 Jul 19.

Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.慢性肾脏病中磷结合剂的益处与危害：随机对照试验的系统评价

Am J Kidney Dis. 2009 Oct;54(4):619-37. doi: 10.1053/j.ajkd.2009.06.004. Epub 2009 Aug 18.

The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis.司维拉姆和镧与含钙及铁基结合剂治疗慢性肾脏病患者高磷血症的疗效和安全性：一项系统评价和荟萃分析。

Nephrol Dial Transplant. 2017 Jan 1;32(1):111-125. doi: 10.1093/ndt/gfw312.

Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.醋酸钙司维拉姆评估-2（CARE-2）研究中的高磷血症

Am J Kidney Dis. 2008 Nov;52(5):1024; author reply 1025. doi: 10.1053/j.ajkd.2008.06.034.

Effectiveness and cost-efficacy of phosphate binders in hemodialysis.血液透析中磷结合剂的有效性和成本效益。

Ann Nutr Metab. 2011 Oct;58(4):315-9. doi: 10.1159/000331988. Epub 2011 Oct 7.

[Clinical aspect of recent progress in phosphate metabolism. Management of hyperphosphagtemia].[磷代谢近期进展的临床方面。高磷血症的管理]

Clin Calcium. 2009 Jun;19(6):844-51.

Oral phosphate binders in patients with kidney failure.肾衰竭患者的口服磷结合剂

N Engl J Med. 2010 Apr 8;362(14):1312-24. doi: 10.1056/NEJMra0912522.

Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease.磷酸盐结合剂对慢性肾脏病患者维生素 D 代谢的影响差异。

Nephrol Dial Transplant. 2020 Apr 1;35(4):616-623. doi: 10.1093/ndt/gfaa010.

引用本文的文献

Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease.klotho与间充质干细胞：慢性肾脏病和急性肾损伤的细胞及基因治疗综述

Pharmaceutics. 2021 Dec 21;14(1):11. doi: 10.3390/pharmaceutics14010011.

Efficacy and safety of calcium carbonate in normophosphataemic patients with chronic kidney disease Stages 3 and 4.碳酸钙对3期和4期慢性肾脏病正常血磷患者的疗效及安全性

Clin Kidney J. 2019 Dec 22;14(2):550-555. doi: 10.1093/ckj/sfz181. eCollection 2021 Feb.

Exosomes, the message transporters in vascular calcification.外泌体：血管钙化中的信息转运体。

J Cell Mol Med. 2018 Sep;22(9):4024-4033. doi: 10.1111/jcmm.13692. Epub 2018 Jun 12.

Treatment of phosphate retention: The earlier the better?磷酸盐潴留的治疗：是否越早越好？

Kidney Res Clin Pract. 2014 Mar;33(1):3-8. doi: 10.1016/j.krcp.2013.11.004. Epub 2014 Feb 3.

αKlotho Mitigates Progression of AKI to CKD through Activation of Autophagy.α-klotho通过激活自噬减轻急性肾损伤向慢性肾病的进展。

J Am Soc Nephrol. 2016 Aug;27(8):2331-45. doi: 10.1681/ASN.2015060613. Epub 2015 Dec 23.

Serum vitamin D and parathyroid hormone profiles in patients with various stages of renal disease.不同阶段肾病患者的血清维生素D和甲状旁腺激素水平

Australas Med J. 2015 Feb 28;8(2):33-40. doi: 10.4066/AMJ.2015.2252. eCollection 2015.

Determinants of coronary artery calcification in maintenance hemodialysis patients.维持性血液透析患者冠状动脉钙化的决定因素

J Artif Organs. 2015 Sep;18(3):251-6. doi: 10.1007/s10047-015-0823-3. Epub 2015 Mar 25.

Lowering vascular calcification burden in chronic kidney disease: Is it possible?降低慢性肾脏病中的血管钙化负担：这可能吗？

World J Nephrol. 2013 Aug 6;2(3):49-55. doi: 10.5527/wjn.v2.i3.49.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验